New Advances

Mavyret Milestone: Acute HCV Treatment

Summary The FDA approved Mavyret (glecaprevir/pibrentasvir) for acute hepatitis C in adults and children down to 3 years old. This marks the first approved DAA treatment for acute HCV, offering an 8-week regimen with a […]

New Advances

Parkinson’s Breakthrough: New Biomarker

Summary Scientists have developed a groundbreaking new biomarker for Parkinson’s disease. This new tool allows for early detection of the disease, even before symptoms appear. This discovery paves the way for earlier intervention and treatment, […]

Diabetes Management

Six Cardiometabolic Risk Profiles in Older Adults

Summary Researchers have confirmed that six cardiometabolic risk profiles, previously identified in middle-aged individuals, also apply to older adults without diabetes. These profiles, or clusters, differ in their risk for type 2 diabetes and associated […]

AI in Medicine

AI-Powered Oncology: Enhancing Cancer Care

Summary AI is revolutionizing cancer treatment by improving diagnosis, personalizing therapies, and mitigating cardiotoxicity risks. This article explores how AI enhances medical imaging, predicts treatment outcomes, and optimizes radiation and radioimmunotherapy while addressing the challenges […]

Pediatric Care

Staph Aureus Threat to Infants

Summary Staphylococcus aureus infections pose a significant risk to infants, especially those born prematurely. Neonatologists face the challenge of managing these infections, particularly in very low birth weight infants who are most vulnerable. This article […]